Skip to main content
BrainCited

Bacopa monnieri Age-Related Cognitive Decline

B

A network meta-analysis found Bacopa outperformed Ginkgo on memory outcomes in elderly participants. Research suggests enhanced delayed word recall and improved Stroop Task performance with consistent supplementation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dbacopa\u002Dmonnieri\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

結論

A network meta-analysis found Bacopa outperformed Ginkgo on memory outcomes in elderly participants. Research suggests enhanced delayed word recall and improved Stroop Task performance with consistent supplementation.

Key Study Findings

Randomized Controlled Trial 6 weeks Double-blind
Effects of Bacopa monnieri herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in …
Dose: 120 mL twice daily for 45 days vs: placebo Outcome: telomerase activity and telomere length 効果: None None

対象集団: elderly participants with MoCA score >=24

Randomized Controlled Trial n=76 12 weeks Double-blind
Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients …
Dose: 300 mg/day standardized Bacopa monnieri extract vs: placebo Outcome: change in composite z score of memory at … 効果: None None

対象集団: patients with amnestic mild cognitive impairment, mean age 62.2 years, 88.3% men

Other
Differential Alterations in the Expression of AMPA Receptor and Its Trafficking Proteins in the Hippocampus …
Dose: 200 mg/kg body weight vs: Rotenone-PD mice without BME Outcome: Recognition memory and AMPA receptor expression 効果: None None

対象集団: Rotenone-induced Parkinson's disease mouse model

Systematic Review
Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer's Treatment: Systematic Review.
Dose: None vs: None Outcome: Cholinesterase inhibition and cognitive improvement 効果: None None

対象集団: In vivo animal models of AD

Other
A systems biology approach reveals dual neurotherapeutic mechanisms of Dioscorea bulbifera in Alzheimer's disease via …
Dose: None vs: Donepezil, Estradiol Outcome: Neurotherapeutic activity via ESR1 and ACHE 効果: None None

対象集団: In silico AD modeling (systems biology)

Systematic Review n=1861
The effect of plant active substances on cognitive function in healthy older adults: a systematic …
Dose: None vs: Placebo or no intervention Outcome: Cognitive function (learning, memory, executive) 効果: Raisin SUCRA 95.1%; tart cherry 89.5% for memory None

対象集団: Healthy older adults

Key Statistics

15

研究数

1200

参加者数

Positive

B

グレード

Referenced Papers

The Senior care … 2021 2 件の引用
Evidence-based complementary and … 2015 82 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
300-600 mg/day standardized to 50% bacosides
memorysupport:
300 mg/day for minimum 8-12 weeks

上限量: Not established; well-tolerated up to 600 mg/day in trials

研究で検討された用量

用量 期間 効果 N
120 mL twice daily for 45 days 6 weeks Neutral --
300 mg/day standardized Bacopa monnieri extract 12 weeks Neutral 76
200 mg/kg body weight -- Positive --
None -- Positive --
None -- Positive --
None -- Positive 1861
None -- Mixed --
None 12 weeks Positive --

推奨摂取タイミング: With meals; effects require 8-12 weeks of consistent use

Safety & Side Effects

報告されている副作用

  • Gastrointestinal discomfort (nausea, cramping, diarrhea)
  • Dry mouth
  • Fatigue in some individuals
  • Mild sedation at higher doses

既知の相互作用

  • Thyroid medications (may increase thyroid hormone levels)
  • Anticholinergic drugs (opposes cholinergic enhancement)
  • Sedative medications (additive CNS depression)
  • Calcium channel blockers (may enhance blood pressure lowering)

耐容上限摂取量: Not established; well-tolerated up to 600 mg/day in trials

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Bacopa monnieri help with Age-Related Cognitive Decline?
Based on 15 studies with 1,200 participants, there is moderate evidence from clinical studies that Bacopa monnieri may support Age-Related Cognitive Decline management. Our evidence grade is B (Good Evidence).
How much Bacopa monnieri should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 300-600 mg/day standardized to 50% bacosides. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bacopa monnieri?
Reported side effects may include Gastrointestinal discomfort (nausea, cramping, diarrhea), Dry mouth, Fatigue in some individuals, Mild sedation at higher doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bacopa monnieri and Age-Related Cognitive Decline?
We rate the evidence as Grade B (Good Evidence). This rating is based on 15 peer-reviewed studies with 1,200 total participants. The overall direction of effect is positive.

Related Evidence

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。